Good news from PB&B: The biotech company developing biodegradable microspheres for natural anti-aging Aesthetics has closed a first seed financing round. In addition the company has been awarded with the Trophée de l'Innovation 2014 of the University Hospitals Geneva (HUG).
PB&B's technology increases fat tissue volume locally with lipids. This provides a natural and longer term alternative to fillers (eg. hyaluronic acid) as the patient's own cells can be used to cover passive wrinkles and rejuvenate mid-facial areas.
The products are developed through a scientific partnership with EPFL and HUG. First preclinical tests showed encouraging results. In addition PB&B won the Trophée de l'Innovation 2014 of HUG due to the technology's potential to solve unpredictability issues with autologous fat transfer in plastic surgery. The trophy is awarded every year at the HUG Innovation Day to highlight particularly innovative projects.
Seed founding
PB&B closed a first CHF300'000 seed founding round recently. However PB&B's CEO Anthony Aho told startupticker that the company actually proceeded in a rolling round for seed financing and would still welcome other investors to the discussion table. A Series A round is planned for autumn 2015. First clinical trials are expected by early-2016.
Please login or sign up to comment.
Commenting guidelines